The Association of Breast Surgery is the association representing healthcare professionals treating malignant and benign breast disease in the UK, Ireland and worldwide. It focuses on education, audit and guidelines to enhance the treatment of patients with breast disease. In 2016 the ABS Conference & AGM will be held at Manchester Central on the 16th & 17th May.
Dr. Tim Rattay will give an oral presentation about The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients on Monday 16th May 2016. The aim of the REQUITE-AB project is to develop an integrated set of predictors for radiotherapy side-effects in breast cancer patients as the primary component of a decision-making tool for clinicians and patients. This article is published in The European Journal of Surgical Oncology - EJSO - Vol. 42, Issue 5 May 2016, S5.